Detalles de la búsqueda
1.
Real-world Impact of Age at Diagnosis on Treatment Patterns and Survival Outcomes of Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Oncologist
; 27(6): 469-475, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278079
2.
Impact of the COVID-19 Pandemic on Management of Patients with Metastatic Pancreatic Ductal Adenocarcinoma in the United States.
Oncologist
; 27(6): e518-e523, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285490
3.
Real-world outcomes associated with liposomal irinotecan dose reductions in metastatic pancreatic ductal adenocarcinoma.
Future Oncol
; 17(6): 675-688, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070660
4.
Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma.
Cancer Med
; 12(8): 9496-9505, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36934451
5.
Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors.
J Health Econ Outcomes Res
; 10(2): 121-131, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38093906
6.
Real-world safety and supportive care use of second-line 5-fluorouracil-based regimens among patients with metastatic pancreatic ductal adenocarcinoma.
Curr Med Res Opin
; 38(8): 1295-1303, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35354375
7.
Costs by Site of Service for Commercially-Insured Patients with Metastatic Pancreatic Cancer Receiving Guideline-Recommended Chemotherapy: Comparing Community Oncology and Hospital Outpatient Settings.
Clinicoecon Outcomes Res
; 14: 653-663, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36250036
8.
The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
Front Oncol
; 11: 754687, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34671563
9.
Real-World Cost of Care for Commercially Insured versus Medicare Patients with Metastatic Pancreatic Cancer Who Received Guideline-Recommended Therapies.
Am Health Drug Benefits
; 14(2): 70-78, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34267862
10.
Real-world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma.
Cancer Med
; 10(24): 8934-8943, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811961
11.
Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan.
Front Oncol
; 11: 678070, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34336666
12.
Comparing real-world evidence among patients with metastatic pancreatic ductal adenocarcinoma treated with liposomal irinotecan.
Ther Adv Med Oncol
; 12: 1758835920944052, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32874209
13.
Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes.
Cancer Med
; 9(22): 8480-8490, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32997898
14.
Correction to: In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits.
Ophthalmol Ther
; 8(2): 347-348, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30783961
15.
A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis.
J Pediatr Ophthalmol Strabismus
; 45(6): 340-9, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19043945
16.
In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits.
Ophthalmol Ther
; 7(1): 157-165, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29761367
17.
An ex vivo human aqueous humor-concentration comparison of two commercial bromfenac formulations.
Clin Ophthalmol
; 12: 943-947, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29849449
18.
Ciprofloxacin/dexamethasone drops decrease the incidence of physician and patient outcomes of otorrhea after tube placement.
Int J Pediatr Otorhinolaryngol
; 71(5): 747-56, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17316832
19.
Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
Clin Ther
; 26(2): 191-6, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15038942
20.
Comparison of topical tobramycin-dexamethasone with dexamethasone-neomycin-polymyxin and neomycin-polymyxin-gramicidin for control of inflammation after cataract surgery: results of a multicenter, prospective, three-arm, randomized, double-masked, controlled, parallel-group study.
Clin Ther
; 26(8): 1274-85, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15476908